Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
Published on: May 3, 2024
Emerging therapeutic approaches for treating abdominal pain
Nestor N Jimenez-Vargas1, Nabil Parkar1, Kaede Takami1
1Gastrointestinal Diseases Research Unit, Kingston Health Sciences Centre, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.
New pain relief strategies target specific nerve cells to reduce side effects. Research explores targeting histamine and proteases in visceral pain and using pH-sensitive drugs for inflammatory pain.
Area of Science:
- Pain research
- Neuroscience
- Pharmacology
Background:
- Existing analgesics like opioids and NSAIDs cause side effects due to non-selective drug actions.
- Drug targets are often widely expressed, leading to off-target effects unrelated to the pain's origin.
- There is a critical need for safer, more effective pain management therapies.
Purpose of the Study:
- To explore two mechanistic approaches for developing targeted analgesics with reduced side effects.
- To focus on visceral nociceptive neurons as a strategy for improved therapeutic specificity.
- To identify novel therapeutic targets and strategies for pain management.
Main Methods:
- Reviewing mechanistic pain studies for specific disorders like irritable bowel syndrome (IBS).
- Investigating neuroactive mediators such as histamine and proteases in visceral pain pathways.
- Examining the use of pH-sensitive analgesics targeting inflamed tissues.
Main Results:
- Mechanistic studies can identify targets upregulated in specific conditions, like IBS.
- Histamine and proteases show potential as therapeutic targets due to their roles in visceral pain.
- pH-sensitive analgesics demonstrate targeted inhibition of μ-opioid receptors in acidic inflammatory environments.
Conclusions:
- Investigating disorder-specific mechanisms is crucial for developing targeted pain therapies.
- Novel biomarkers and therapeutic strategies can enhance treatment specificity and reduce side effects.
- Targeting visceral nociceptive neurons offers a promising avenue for safer pain relief.
More Related Videos
05:18Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Analgesia and Pain Management
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS